NL194203B - 1,4-dihydropyridineverbindingen en farmaceutisch preparaat dat ÚÚn of meer van deze bevat. - Google Patents

1,4-dihydropyridineverbindingen en farmaceutisch preparaat dat ÚÚn of meer van deze bevat.

Info

Publication number
NL194203B
NL194203B NL8204014A NL8204014A NL194203B NL 194203 B NL194203 B NL 194203B NL 8204014 A NL8204014 A NL 8204014A NL 8204014 A NL8204014 A NL 8204014A NL 194203 B NL194203 B NL 194203B
Authority
NL
Netherlands
Prior art keywords
pharmaceutical composition
composition containing
dihydropyridine compounds
dihydropyridine
compounds
Prior art date
Application number
NL8204014A
Other languages
English (en)
Other versions
NL8204014A (nl
NL194203C (nl
Original Assignee
Maruko Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP16696381A external-priority patent/JPS5867668A/ja
Priority claimed from JP259782A external-priority patent/JPS58121288A/ja
Priority claimed from JP2839182A external-priority patent/JPS58146565A/ja
Application filed by Maruko Pharmaceutical Co filed Critical Maruko Pharmaceutical Co
Publication of NL8204014A publication Critical patent/NL8204014A/nl
Publication of NL194203B publication Critical patent/NL194203B/nl
Application granted granted Critical
Publication of NL194203C publication Critical patent/NL194203C/nl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/18Radicals substituted by singly bound oxygen or sulfur atoms
    • C07D317/24Radicals substituted by singly bound oxygen or sulfur atoms esterified
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NL8204014A 1981-10-19 1982-10-18 1,4-dihydropyridineverbindingen en farmaceutisch preparaat dat ÚÚn of meer van deze bevat. NL194203C (nl)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
JP16696381A JPS5867668A (ja) 1981-10-19 1981-10-19 1,4−ジヒドロピリジン誘導体
JP16696381 1981-10-19
JP259782A JPS58121288A (ja) 1982-01-11 1982-01-11 1,4−ジヒドロピリジン誘導体
JP259782 1982-01-11
JP2839182A JPS58146565A (ja) 1982-02-24 1982-02-24 1,4−ジヒドロピリジン誘導体
JP2839182 1982-02-24

Publications (3)

Publication Number Publication Date
NL8204014A NL8204014A (nl) 1983-05-16
NL194203B true NL194203B (nl) 2001-05-01
NL194203C NL194203C (nl) 2001-09-04

Family

ID=27275435

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8204014A NL194203C (nl) 1981-10-19 1982-10-18 1,4-dihydropyridineverbindingen en farmaceutisch preparaat dat ÚÚn of meer van deze bevat.

Country Status (12)

Country Link
US (1) US4446325A (nl)
KR (1) KR880002704B1 (nl)
AU (1) AU555036B2 (nl)
CA (1) CA1177079A (nl)
CH (1) CH650498A5 (nl)
DE (1) DE3238705A1 (nl)
ES (2) ES8406439A1 (nl)
FR (1) FR2514761B1 (nl)
GB (1) GB2111978B (nl)
IT (1) IT1189393B (nl)
NL (1) NL194203C (nl)
SE (1) SE442864B (nl)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE57810B1 (en) * 1984-03-27 1993-04-21 Delagrange Lab 1,4-dihydropyridine derivatives,their preparation and their use
FR2577552B1 (fr) * 1985-02-20 1987-09-04 Sori Soc Rech Ind Esters heterocycliques dissymetriques d'acides 1,4-dihydropyridine-3,5-dicarboxyliques, procede de preparation et utilisation en therapeutique
US4833150A (en) * 1985-03-14 1989-05-23 Nelson Research & Development Co. 1,4-dihydropyridines
DE3514865A1 (de) * 1985-04-25 1986-11-06 Bayer Ag, 5090 Leverkusen 1,4-dihydropyridin-derivate, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
US4849436A (en) * 1986-03-11 1989-07-18 Nelson Research & Development Co. 1,4-dihydropyridines
ATE68704T1 (de) * 1986-12-18 1991-11-15 Bauer Kurt Heinz Gegenueber lichteinfluss stabilisiertes nifedipin- konzentrat und verfahren zu seiner herstellung.
CN100450483C (zh) * 2000-04-11 2009-01-14 三共株式会社 含有钙阻滞剂的稳定药物组合物
CN1681495B (zh) 2002-08-19 2010-05-12 辉瑞产品公司 用于治疗过度增生性疾病的组合物
BRPI0513866A (pt) * 2004-07-26 2008-05-20 Cotherix Inc composição, micropartìculas, método para o tratamento da hipertensão pulmonar, e dispositivo de inalação
US7893050B2 (en) * 2005-10-26 2011-02-22 Asahi Kasei Pharma Corporation Fasudil in combination therapies for the treatment of pulmonary arterial hypertension
EP2351569B1 (en) 2005-10-26 2012-08-22 Asahi Kasei Pharma Corporation Fasudil in combination therapies for the treatment of pulmonary arterial hypertension
TW200736245A (en) * 2005-11-29 2007-10-01 Sankyo Co Acid addition salts of optically active dihydropyridine derivatives
TW200806648A (en) * 2005-11-29 2008-02-01 Sankyo Co Acid addition salts of dihydropyridine derivatives
US8883844B2 (en) 2010-09-24 2014-11-11 Nitrogenix Inc. Nitric oxide releasing amino acid ester for treatment of pulmonary hypertension and other respiratory conditions
BR112014004370A2 (pt) 2011-08-26 2017-03-21 Wockhardt Ltd métodos para tratar distúrbios cardiovasculares

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1670827C3 (de) * 1967-03-20 1974-10-24 Bayer Ag, 5090 Leverkusen 4-(2'-Nitrophenyl)-2,6-dimethyl-3,5-dicarbmethoxy-1,4-dihydropyridin
DE1670824C3 (de) * 1967-03-20 1978-08-03 Bayer Ag, 5090 Leverkusen 1,4-Dihydropyridin-33-dicarbonsäurealkylester
DE2228363A1 (de) * 1972-06-10 1974-01-03 Bayer Ag 1,4-dihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE2747513A1 (de) * 1977-10-22 1979-05-03 Bayer Ag Dihydropyridine mit schwefelhaltigen estergruppierungen
DE2847236A1 (de) * 1978-10-31 1980-05-14 Bayer Ag Neue dihydropyridine mit substituierten estergruppierungen, mehrer verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE2935451A1 (de) * 1979-09-01 1981-03-19 Bayer Ag, 5090 Leverkusen Optisch aktive 1,4-dihydropyridine, verfahren zu ihrer herstellung und ihre verwendung als arneimittel
NZ201395A (en) * 1981-07-30 1987-02-20 Bayer Ag Pharmaceutical compositions containing 1,4-dihydropyridines and certain of these dihydropyridines

Also Published As

Publication number Publication date
GB2111978A (en) 1983-07-13
US4446325A (en) 1984-05-01
GB2111978B (en) 1985-05-01
KR840001954A (ko) 1984-06-07
IT1189393B (it) 1988-02-04
DE3238705A1 (de) 1983-07-14
NL8204014A (nl) 1983-05-16
ES8504127A1 (es) 1985-04-16
AU555036B2 (en) 1986-09-11
FR2514761B1 (fr) 1985-09-06
AU8931782A (en) 1983-04-28
IT8249295A0 (it) 1982-10-18
ES517022A0 (es) 1984-08-16
SE442864B (sv) 1986-02-03
ES8406439A1 (es) 1984-08-16
CH650498A5 (de) 1985-07-31
SE8205905L (sv) 1983-04-20
KR880002704B1 (ko) 1988-12-26
CA1177079A (en) 1984-10-30
DE3238705C2 (nl) 1989-11-09
FR2514761A1 (fr) 1983-04-22
NL194203C (nl) 2001-09-04
SE8205905D0 (sv) 1982-10-18
ES527980A0 (es) 1985-04-16

Similar Documents

Publication Publication Date Title
NL184364C (nl) Carbostyrilderivaten en zouten daarvan, alsmede gevormd farmaceutisch preparaat dat een of meer van dergelijke carbostyrilverbindingen bevat.
DE3265978D1 (en) 1,4-dihydropyridine derivative and pharmaceutical composition containing same
IT8019049A0 (it) Composti 2 penem, metodo per laloro preparazione e composizioni farmaceutiche contenenti tali composti.
MX9203176A (es) 1,2,4-triazolonas substituidas con fenoxietilo y composiciones farmaceuticas que las contienen.
NL190553B (nl) Gesubstitueerde (2-imidazolin-2-yl)aminopirimidinen, alsmede farmaceutisch preparaat met antihypertensieve werking, dat een of meer van deze verbindingen bevat.
DK165949C (da) 1,4-dihydropyridinderivater, fremgangsmaader til fremstilling deraf og farmaceutiske praeparater indeholdende forbindelserne
DE3267350D1 (en) 5,6,7-trinor-4,8-inter-m-phenylene pgi derivatives and pharmaceutical compositions containing them
BE892805A (fr) Cycloalcanes substitues et compositions pharmaceutiques les contenant
IT8721411A0 (it) Composizione farmaceutica idrosolubile contenente n acetilsisteina.
DK163923C (da) 2-phenyl-3-aminomethyl-imidazooe1,2-aaapyridinderivater og farmaceutisk praeparat indeholdende saadanne forbindelser
FI822683A0 (fi) Inert fyllnadsmaterial foer farmaceutiska kompositioner
NL194203B (nl) 1,4-dihydropyridineverbindingen en farmaceutisch preparaat dat ÚÚn of meer van deze bevat.
MX9203099A (es) N-heterociclico-n-(4-piperidia)amidas y composiciones farmaceuticas y metodos que emplean dichos compuestos.
NL990010I2 (nl) Ä3HÜ-imidazo-Ä5,1-dÜ-1,2,3,5-tetrazine-4-on derivaten en farmaceutische samenstellingen, die deze d erivaten bevatten.
IT8721410A0 (it) Composizione farmaceutica idrosolubile contenente n acetilcisteina.
DE3579730D1 (de) Eisen-3-hydroxypyron- oder 3-hydroxypyridon-komplexe und diese enthaltende pharmazeutische zusammensetzungen.
FI883673A (fi) Farmaceutiska kompositioner.
IT1193847B (it) Composizione farmaceutica contenente 3,4-di-idro-3-osso-2-chinossaline
IT1140978B (it) 1-(4-clorobenzidril)-4-(2,3-diidros sipropil)-piperazina, metodi per la sua preparazione e relative composizione farmaceutiche
NL190485C (nl) alfa-Fluormethyl-alfa-aminoalkaanzuurderivaat, farmaceutisch preparaat dat één of meer zodanige verbindingen bevat, alsmede werkwijze voor het bereiden van de verbindingen.
PH16694A (en) Platinum compounds and pharmaceutical composition thereof
FR2528425B1 (fr) 1,4-dihydropyridines et composition pharmaceutique les contenant
NL187168C (nl) 3 beta-oxygesubstitueerde-18 beta-olean-30-carboxyderivaten, werkwijze ter bereiding daarvan en farmaceutische preparaten welke een of meer van deze verbindingen bevatten.
NO159844C (no) Eske for lagring og klarholding av gjenstander.
DK164670C (da) Pyrrolooe3,2,1-hiaaindol-derivater, fremgangsmaade til fremstilling deraf samt laegemidler indeholdende saadanne forbindelser

Legal Events

Date Code Title Description
A85 Still pending on 85-01-01
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
V4 Discontinued because of reaching the maximum lifetime of a patent

Free format text: 20021018